StockDriftsStockDriftsTop 3 Trv Gp VI LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| SEPN | SEPTERNA, INC. | 60.72% | 4.21M | $141.0M | +0.00%(+0) | $20.75(+110.02%) | 2026-06-30 | |
| RAPP | RAPPORT THERAPEUTICS, INC. | 17.39% | 969.2K | $40.4M | +0.00%(+0) | $19.11(+151.99%) | 2026-06-30 | |
| TNGX | TANGO THERAPEUTICS, INC. | 2.61% | 194.2K | $6.1M | +0.00%(+0) | $5.39(+396.76%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (6 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — | +47.38% |
| Top 20 Holdings Unweighted | — | — | — | — | +213.14% |
Trv Gp VI LLC reports $232.28M in US-listed equity holdings across 4 positions in its most recent 13F filing. Its largest disclosed positions are SEPN (60.7%), RAPP (17.4%) and TNGX (2.6%). The top 20 holdings account for 80.72% of reported assets. Its disclosed equity book has returned +47.38% cumulatively over 6 quarters. Figures reflect the Q2 2026 filing.
Sign up free to track Trv Gp VI LLC, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Trv Gp VI LLC’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1990716). View Trv Gp VI LLC’s 13F filings on SEC